Antagonists of the human A2A receptor. Part 5: Highly bio-available pyrimidine-4-carboxamides

被引：25

作者：

Gillespie, Roger J. ^{[2
]}

Bamford, Samantha J. ^{[2
]}

Gaur, Suneel ^{[2
]}

Jordan, Allan M. ^{[1
]}

Lerpiniere, Joanne ^{[2
]}

Mansell, Howard L. ^{[2
]}

Stratton, Gemma C. ^{[2
]}

机构：

[1] Vernalis R D Ltd, Cambridge CB21 6GB, England

[2] Vernalis R D Ltd, Winnersh Wokingham RG41 5UA, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 10期

关键词：

Adenosine receptor; Parkinson's disease; Pyrimidine; Carboxamide; PARKINSONS-DISEASE; L-DOPA; ADENOSINE; DESIGN; DERIVATIVES; DYSKINESIA; AGONISTS; KW-6002; MONKEYS; POTENT;

D O I：

10.1016/j.bmcl.2009.03.142

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A novel series of antagonists of the human A(2A) receptor have been identified and have been shown to display good potency and high degrees of selectivity over other receptor sub-types. Displaying in vivo potency in commonly used disease models and high oral bio-availability, this class of compounds may serve as clinically useful treatments for the relief of the symptoms associated with Parkinson's disease. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：2664 / 2667

页数：4

共 50 条

[31] 2-(2-furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs:: Highly potent, orally active, adenosine A2A antagonists.: Part 1
Matasi, JJ
Caldwell, JP
Zhang, HT
Fawzi, A
Cohen-Williams, ME
Varty, GB
Tulshian, DB
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (16) : 3670 - 3674
[32] Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 2: Discovery of potent, selective, and orally bioavailable compounds
Shen, DM
Shu, M
Willoughby, CA
Shah, S
Lynch, CL
Hale, JJ
Mills, SG
Chapman, KT
Malkowitz, L
Springer, MS
Gould, SL
DeMartino, JA
Siciliano, SJ
Lyons, K
Pivnichny, JV
Kwei, GY
Carella, A
Carver, G
Holmes, K
Schleif, WA
Danzeisen, R
Hazuda, D
Kessler, J
Lineberger, J
Miller, MD
Emini, EA
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (04) : 941 - 945
[33] Antioxidant-Conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain
Falsini, Matteo
Catarzi, Daniela
Varano, Flavia
Ceni, Costanza
Dal Ben, Diego
Marucci, Gabriella
Buccioni, Michela
Volpini, Rosaria
Mannelli, Lorenzo Di Cesare
Lucarini, Elena
Ghelardini, Carla
Bartolucci, Gianluca
Menicatti, Marta
Colotta, Vittoria
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (18) : 8511 - 8531
[34] Discovery of piperidine-4-carboxamides as potent chemokine receptor CCR2b antagonists, Part I: Structure-based design and structure-activity relationship studies
Lin, Jian
Melendez, Rosa
Mohanty, Pradyumna
Koerner, Steffi
Fichman, Merav
Ben-Zeev, Efrat
McCauley, Dilara
Kolodziej, Andrew
Kitsos, Christine
Jacques, Vincent
Deng, Qing
Chen, Dongli
Das, Biplab
Shacham, Sharon
Jones, Simon
Marantz, Yael
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
[35] Discovery of piperidine-4-carboxamides as potent chemokine receptor CCR2b antagonists, Part II: Reduction of hERG ion channel affinity and CYP450 liability
Mohanty, Pradyumna
Koerner, Steffi
Melendez, Rosa
Lin, Jian
Chen, Dongli
Fichman, Merav
Ben-Zeev, Efrat
McCauley, Dilara
Kolodziej, Andrew
Kitsos, Christine
Jacques, Vincent
Deng, Qing
Das, Biplab
Shacham, Sharon
Jones, Simon
Ghosh, Shomir
Dewitt, Sheila
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
[36] Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: Highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1" binding site
Nara, Hiroshi
Sato, Kenjiro
Naito, Takako
Mototani, Hideyuki
Oki, Hideyuki
Yamamoto, Yoshio
Kuno, Haruhiko
Santou, Takashi
Kanzaki, Naoyuki
Terauchi, Jun
Uchikawa, Osamu
Kori, Masakuni
BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (19) : 5487 - 5505
[37] The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2A Receptor Subtype
Falsini, Matteo
Squarcialupi, Lucia
Catarzi, Daniela
Varano, Flavia
Betti, Marco
Dal Ben, Diego
Marucci, Gabriella
Buccioni, Michela
Volpini, Rosaria
De Vita, Teresa
Cavalli, Andrea
Colotta, Vittoria
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (13) : 5772 - 5790
[38] Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segment
Shu, M
Loebach, JL
Parker, KA
Mills, SG
Chapman, KT
Shen, DM
Malkowitz, L
Springer, MS
Gould, SL
DeMartino, JA
Siciliano, SJ
Di Salvo, J
Lyons, K
Pivnichny, JV
Kwei, GY
Carella, A
Carver, G
Holmes, K
Schleif, WA
Danzeisen, R
Hazuda, D
Kessler, J
Lineberger, J
Miller, MD
Emini, EA
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (04) : 947 - 952
[39] Optimization of alkylidene hydrazide based human glucagon receptor antagonists.: Discovery of the highly potent and orally available 3-cyano-4-hydroxybenzoic acid [1-(2,3,5,6-tetramethylbenzyl)-1H-indol-4-ylmethylene]hydrazide
Madsen, P
Ling, A
Plewe, M
Sams, CK
Knudsen, LB
Sidelmann, UG
Ynddal, L
Brand, CL
Andersen, B
Murphy, D
Teng, M
Truesdale, L
Kiel, D
May, J
Kuki, A
Shi, SH
Johnson, MD
Teston, KA
Feng, J
Lakis, J
Anderes, K
Gregor, V
Lau, J
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (26) : 5755 - 5775
[40] The role of 5-arylalkylamino-and 5-piperazino-moieties on the 7-aminopyrazolo[4,3-d] pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles
Squarcialupi, Lucia
Betti, Marco
Catarzi, Daniela
Varano, Flavia
Falsini, Matteo
Ravani, Annalisa
Pasquini, Silvia
Vincenzi, Fabrizio
Salmaso, Veronica
Sturlese, Mattia
Varani, Katia
Moro, Stefano
Colotta, Vittoria
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2017, 32 (01) : 248 - 263

← 1 2 3 4 5 →